Nanjing Immunophage Biotech Co., Ltd

This study tests a new drug (IPG7236) combined with an immunotherapy (toripalimab) in adults with advanced solid tumors that have spread or cannot be removed. The goal is to check safety, how the body processes the drugs, and whether they shrink tumors. About 52 people will join …

This study tests an experimental pill, IPG11406, in 144 adults with moderate-to-severe ulcerative colitis, a chronic gut condition causing pain and diarrhea. Participants receive one of three doses or a placebo for 12 weeks to see if the drug reduces inflammation and symptoms. Th…